Danaher
Open
$181.57
Prev. Close
$181.58
High
$181.85
Low
$181.30
Market Snapshot
$128.24B
34.8
5.33
$23.88B
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Recently from Cashu
Danaher Strengthens Financial Position with €3 Billion Notes and Confirms Quarterly Dividend
Danaher Corporation (Ticker: DHR) has recently made strides to solidify its financial strength and enhance returns for its investors amid a cautious market environment. The company has strategically i…
Danaher’s Leica Biosystems Unveils Advanced Digital Pathology Solutions to Enhance Cancer Diagnostics
Revolutionizing Digital Pathology: Danaher’s Leica Biosystems Launches Advanced Solutions Leica Biosystems, a prominent subsidiary of Danaher, announces the launch of its cutting-edge Aperio GT Elite™…
Investigation Launched into Corporate Governance Issues at Danaher Corporation
Corporate Governance Concerns Prompt Investigations into Danaher Corporation Halper Sadeh LLC, a law firm specializing in investor rights, initiates an investigation into potential breaches of fiducia…
Investor Rights Firm Investigates Corporate Governance Issues at Danaher Corporation
Investor Rights Firm Investigates Danaher’s Corporate Governance Halper Sadeh LLC, a law firm specializing in investor rights, has initiated an investigation into the fiduciary duties of certain offic…